Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.

BMJ Open · 2023 · PMC9971831 · PMID 36828654

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

trending toward significancep=0.053so close (0.05 < p ≤ 0.1)

The significance of this result remains unclear and should be interpreted with caution given the interaction is only trending toward significance (p=0.053) and could be the result of multiple testing.

also in 580 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.